Li Xue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Xue has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Huashan Zhao
Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Jian V. Zhang
Center for Energy Metabolism and Reproduction, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Tianxia Xiao
Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Yali Yang
Shenzhen Metabolism and Reproductive Targeted Delivery Proof-of-Concept Center, Shenzhen Institutes of Advanced Technology, Shenzhen, Guangdong, 518000, China.
2 shared publications - Baobei Wang
Center for Energy Metabolism and Reproduction, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
1 shared publication - Baohua Ma
College of Veterinary Medicine, Northwest A&F University
1 shared publication
Latest Publications
- Open Access
Development and Validation of a Universal Eating Monitor (UEM) for Distinguishing the Intake of Multiple Foods and Macronutrients
Background/Objectives: Dietary microstructure affects energy intake. Traditional Universal Eating Monitors (UEMs) offer accuracy but are limited for monitoring diverse diets. We developed the ‘Feeding Table’, a novel UEM that simultaneously tracks intake of up to 12 foods, enabling high-resolution monitoring of eating microstructure for multiple foods simultaneously. Methods: Forty-nine healthy volunteers participated: 15 (10 male, 8 female) in a location preference experiment and 31 (15 male, 16 female) in a standard meal test. The location preference study involved four weekly sessions. Participants received a standardized breakfast based on individual energy needs; lunch intake was measured 3 h later with food items in pseudo-randomized positions. The standard meal test occurred over two consecutive days to assess the Feeding Table’s performance in monitoring eating behavior under standardized conditions. Results: In two consecutive days of standard meal tests, the Feeding Table showed reasonable day-to-day repeatability for energy and macronutrient intake (energy: r = 0.82; fat: r = 0.86; carbohydrate: r = 0.86; protein: r = 0.58). Among the four repeated intake measurements, the results demonstrated high intra-class correlation coefficients (ICCs: energy 0.94, protein 0.90, fat 0.90, and carbohydrate 0.93). No significant positional bias was observed (energy: p = 0.07; macronutrients: p = 0.70). Conclusions: The Feeding Table maintains UEM accuracy while enabling multi-food, real-time monitoring of dietary microstructure and food choice, offering enhanced precision for studying eating behaviors.
Open AccessDevelopment and Validation of a Universal Eating Monitor (UEM) for Distinguishing the Intake of Multiple Foods and Macronutrients
Background/Objectives: Dietary microstructure affects energy intake. Traditional Universal Eating Monitors (UEMs) offer accuracy but are limited for monitoring diverse diets. We developed the ‘Feeding Table’, a novel UEM that simultaneously tracks intake of up to 12 foods, enabling high-resolution monitoring of eating microstructure for multiple foods simultaneously. Methods: Forty-nine healthy volunteers participated: 15 (10 male, 8 female) in a location preference experiment and 31 (15 male, 16 female) in a standard meal test. The location preference study involved four weekly sessions. Participants received a standardized breakfast based on individual energy needs; lunch intake was measured 3 h later with food items in pseudo-randomized positions. The standard meal test occurred over two consecutive days to assess the Feeding Table’s performance in monitoring eating behavior under standardized conditions. Results: In two consecutive days of standard meal tests, the Feeding Table showed reasonable day-to-day repeatability for energy and macronutrient intake (energy: r = 0.82; fat: r = 0.86; carbohydrate: r = 0.86; protein: r = 0.58). Among the four repeated intake measurements, the results demonstrated high intra-class correlation coefficients (ICCs: energy 0.94, protein 0.90, fat 0.90, and carbohydrate 0.93). No significant positional bias was observed (energy: p = 0.07; macronutrients: p = 0.70). Conclusions: The Feeding Table maintains UEM accuracy while enabling multi-food, real-time monitoring of dietary microstructure and food choice, offering enhanced precision for studying eating behaviors.
- Open Access
- 7 August 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (8) , 1910
Chemerin: A Functional Adipokine in Reproductive Health and Diseases
As a multifaceted adipokine, chemerin has been found to perform functions vital for immunity, adiposity, and metabolism through its three known receptors (chemokine-like receptor 1, CMKLR1; G-protein-coupled receptor 1, GPR1; C-C motif chemokine receptor-like 2, CCRL2). Chemerin and the cognate receptors are also expressed in the hypothalamus, pituitary gland, testis, ovary, and placenta. Accumulating studies suggest that chemerin participates in normal reproduction and underlies the pathological mechanisms of certain reproductive system diseases, including polycystic ovary syndrome (PCOS), preeclampsia, and breast cancer. Herein, we present a comprehensive review of the roles of the chemerin system in multiple reproductive processes and human reproductive diseases, with a brief discussion and perspectives on future clinical applications.
- 7 August 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (8) , 1910
Open AccessChemerin: A Functional Adipokine in Reproductive Health and Diseases
As a multifaceted adipokine, chemerin has been found to perform functions vital for immunity, adiposity, and metabolism through its three known receptors (chemokine-like receptor 1, CMKLR1; G-protein-coupled receptor 1, GPR1; C-C motif chemokine receptor-like 2, CCRL2). Chemerin and the cognate receptors are also expressed in the hypothalamus, pituitary gland, testis, ovary, and placenta. Accumulating studies suggest that chemerin participates in normal reproduction and underlies the pathological mechanisms of certain reproductive system diseases, including polycystic ovary syndrome (PCOS), preeclampsia, and breast cancer. Herein, we present a comprehensive review of the roles of the chemerin system in multiple reproductive processes and human reproductive diseases, with a brief discussion and perspectives on future clinical applications.
- Open Access
- 9 June 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (6) , 857
An Antagonistic Peptide of Gpr1 Ameliorates LPS-Induced Depression through the Hypothalamic-Pituitary-Ovarian Axis
Depression affects the reproductive axis at the hypothalamus and pituitary levels, which has a significant impact on female fertility. It has been reported that G protein-coupled receptor 1 (Gpr1) mRNA is expressed in both the hypothalamus and ovaries. However, it is unclear whether there is a relationship between Gpr1 and depression, and its role in ovarian function is unknown. Here, the expression of Gpr1 was recorded in the hypothalamus of normal female mice, and co-localized with gonadotrophin-releasing hormone (GnRH) and corticotropin-releasing factor (CRF). We established a depression mouse model to evaluate the antidepressant effect of G5, an antagonistic peptide of Gpr1. The results show that an intraperitoneal injection of G5 improves depressant–like behaviors remarkably, including increased sucrose intake in the sucrose preference test and decreased immobility time in the forced swimming tests. Moreover, G5 treatment increased the release of reproductive hormone and the expression of ovarian gene caused by depression. Together, our findings reveal a link between depression and reproductive diseases through Gpr1 signaling, and suggest antagonistic peptide of Gpr1 as a potential therapeutic application for hormone-modulated depression in women.
- 9 June 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (6) , 857
Open AccessAn Antagonistic Peptide of Gpr1 Ameliorates LPS-Induced Depression through the Hypothalamic-Pituitary-Ovarian Axis
Depression affects the reproductive axis at the hypothalamus and pituitary levels, which has a significant impact on female fertility. It has been reported that G protein-coupled receptor 1 (Gpr1) mRNA is expressed in both the hypothalamus and ovaries. However, it is unclear whether there is a relationship between Gpr1 and depression, and its role in ovarian function is unknown. Here, the expression of Gpr1 was recorded in the hypothalamus of normal female mice, and co-localized with gonadotrophin-releasing hormone (GnRH) and corticotropin-releasing factor (CRF). We established a depression mouse model to evaluate the antidepressant effect of G5, an antagonistic peptide of Gpr1. The results show that an intraperitoneal injection of G5 improves depressant–like behaviors remarkably, including increased sucrose intake in the sucrose preference test and decreased immobility time in the forced swimming tests. Moreover, G5 treatment increased the release of reproductive hormone and the expression of ovarian gene caused by depression. Together, our findings reveal a link between depression and reproductive diseases through Gpr1 signaling, and suggest antagonistic peptide of Gpr1 as a potential therapeutic application for hormone-modulated depression in women.